A pox on your practice. iPLEDGE program scars dermatologists.
Ortolon
Ken
K
ken.ortolon@texmed.org
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000152:Acne Vulgaris / Q000188:drug therapy; D003284:Contract Services / Q000592:standards*; D003879:Dermatologic Agents / Q000009:adverse effects / Q000600:supply & distribution*; D003880:Dermatology / Q000331:legislation & jurisprudence; D011307:Drug Prescriptions; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects / Q000600:supply & distribution*; D007885:Legislation, Pharmacy; D008297:Male; D011247:Pregnancy; D012042:Registries / Q000592:standards*; D012984:Software; D014481:United States; D014486:United States Food and Drug Administration
D003879:Dermatologic Agents; D015474:Isotretinoin